Neuphoria enters deal to merge with Scancell

Neuphoria Therapeutics Inc. has entered into an agreement to merge with Scancell Holdings PLC and its wholly-owned subsidiary, Scancell Merger Sub, Inc. This deal represents a strategic step in the company's growth trajectory and will involve the combination of the two entities.